about CaringBridge  |  home page  |  view guestbook  |  view photos  |  read journal history  |  make a tribute donation
 
 

Brady Martin Foxe

Welcome to Brady's Web Page. It has been provided to keep family and friends updated about Brady's life with Neuroblastoma.

Brady was diagnosed on Febuary 10, 2005 with high risk stage IV Neuroblastoma. Since then, he has had 11 cycles of chemo, two surgery's, two stem cell harvests, MIBG Radiation therapy, a stem cell transplant, accutane, 3 cycles of Irinotecan and Temodar, 3 cylces of Topotecan, Cyclophosphamide and a phase one study drug called Nifurtimox, 5 drug regimen of Anti-Angiogenic Chemotherapy, Rapamacyin and Vinblastine, a phase 1 trial of TPI and Temodar and now is currenly taking DFMO

Brady has a long road ahead of him so please keep him in your thoughts and prayers.

Locations of visitors to this page


Journal

Thursday, November 24, 2011 11:35 AM CST

Hello Family and Friends,

HAPPY THANKSGIVING!!!!!

We are very thankful that we are all together, happy, healthy, and very much loved.

Enjoy your day everyone and let your loved ones know how thankful you are.

Read Journal History


Sign and view the guestbook
Sign and View Guestbook

View personal photos

View Photos

 
 

E-mail Author: foxex4@yahoo.com

 
 

  Celebrate someone you love with a Tribute Gift to CaringBridge

Your gift will help millions of people stay connected with friends and loved ones during challenging times.


 

This page has been viewed 43572 times.

 

Note: The foregoing information was authored by the patient, parent or guardian, or other parties who are solely responsible for the content. Such announcements or their content are not necessarily endorsed by CaringBridge, Inc. or any sponsoring agent.  This information does not confirm that anyone is or was actually a patient at any facility.
 
 
Copyright Policy  |  Privacy Policy  |  Terms of Use  |  Donate |  How to Help |  Contact Us  |  FAQs
Copyright © 1997-2005 CaringBridge, a nonprofit organization. All rights reserved.
 
Visit the Onvoy website